AI Pharma Market, Global Outlook and Forecast 2023-2029

Report ID: MMG184110 | Category: Service & Software | Pages: 114 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for AI Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Pharma. This report contains market size and forecasts of AI Pharma in global, including the following market information:
Global AI Pharma Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global AI Pharma market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Self-developed Oipeline Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of AI Pharma include Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrödinger, Lantern Pharma and XtalPi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the AI Pharma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AI Pharma Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global AI Pharma Market Segment Percentages, by Type, 2022 (%)
    Self-developed Oipeline
    Contract Research Organization (CRO)
    Other
Global AI Pharma Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global AI Pharma Market Segment Percentages, by Application, 2022 (%)
    Preclinical Stage (Optimization of Lead Compounds, etc.)
    Clinical Trial Phase (Predicting Treatment Outcome, etc.)
Global AI Pharma Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global AI Pharma Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AI Pharma revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies AI Pharma revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Recursion
    Insilico Medicine
    Exscientia
    BenevolentAI
    Atomwise
    Roivant Sciences
    Schrödinger
    Lantern Pharma
    XtalPi
    Landos Biopharma
    Relay Therapeutics
    Accutar Biotech
    Deep Genomics
    Oncocross
    AI Therapeutics
    BioMap
    METiS Pharmaceuticals
    NeoX Biotech
    StoneWise
    Deep Intelligent Pharma
    Gigaceuticals
    Chemical.AI
    Artivila
    Galixir
    Xbiome
Outline of Major Chapters:
Chapter 1: Introduces the definition of AI Pharma, market overview.
Chapter 2: Global AI Pharma market size in revenue.
Chapter 3: Detailed analysis of AI Pharma company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of AI Pharma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 AI Pharma Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global AI Pharma Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global AI Pharma Overall Market Size
    2.1 Global AI Pharma Market Size: 2022 VS 2029
    2.2 Global AI Pharma Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top AI Pharma Players in Global Market
    3.2 Top Global AI Pharma Companies Ranked by Revenue
    3.3 Global AI Pharma Revenue by Companies
    3.4 Top 3 and Top 5 AI Pharma Companies in Global Market, by Revenue in 2022
    3.5 Global Companies AI Pharma Product Type
    3.6 Tier 1, Tier 2 and Tier 3 AI Pharma Players in Global Market
        3.6.1 List of Global Tier 1 AI Pharma Companies
        3.6.2 List of Global Tier 2 and Tier 3 AI Pharma Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global AI Pharma Market Size Markets, 2022 & 2029
        4.1.2 Self-developed Oipeline
        4.1.3 Contract Research Organization (CRO)
        4.1.4 Other
    4.2 By Type - Global AI Pharma Revenue & Forecasts
        4.2.1 By Type - Global AI Pharma Revenue, 2018-2023
        4.2.2 By Type - Global AI Pharma Revenue, 2024-2029
        4.2.3 By Type - Global AI Pharma Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global AI Pharma Market Size, 2022 & 2029
        5.1.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
        5.1.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
    5.2 By Application - Global AI Pharma Revenue & Forecasts
        5.2.1 By Application - Global AI Pharma Revenue, 2018-2023
        5.2.2 By Application - Global AI Pharma Revenue, 2024-2029
        5.2.3 By Application - Global AI Pharma Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global AI Pharma Market Size, 2022 & 2029
    6.2 By Region - Global AI Pharma Revenue & Forecasts
        6.2.1 By Region - Global AI Pharma Revenue, 2018-2023
        6.2.2 By Region - Global AI Pharma Revenue, 2024-2029
        6.2.3 By Region - Global AI Pharma Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America AI Pharma Revenue, 2018-2029
        6.3.2 US AI Pharma Market Size, 2018-2029
        6.3.3 Canada AI Pharma Market Size, 2018-2029
        6.3.4 Mexico AI Pharma Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe AI Pharma Revenue, 2018-2029
        6.4.2 Germany AI Pharma Market Size, 2018-2029
        6.4.3 France AI Pharma Market Size, 2018-2029
        6.4.4 U.K. AI Pharma Market Size, 2018-2029
        6.4.5 Italy AI Pharma Market Size, 2018-2029
        6.4.6 Russia AI Pharma Market Size, 2018-2029
        6.4.7 Nordic Countries AI Pharma Market Size, 2018-2029
        6.4.8 Benelux AI Pharma Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia AI Pharma Revenue, 2018-2029
        6.5.2 China AI Pharma Market Size, 2018-2029
        6.5.3 Japan AI Pharma Market Size, 2018-2029
        6.5.4 South Korea AI Pharma Market Size, 2018-2029
        6.5.5 Southeast Asia AI Pharma Market Size, 2018-2029
        6.5.6 India AI Pharma Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America AI Pharma Revenue, 2018-2029
        6.6.2 Brazil AI Pharma Market Size, 2018-2029
        6.6.3 Argentina AI Pharma Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa AI Pharma Revenue, 2018-2029
        6.7.2 Turkey AI Pharma Market Size, 2018-2029
        6.7.3 Israel AI Pharma Market Size, 2018-2029
        6.7.4 Saudi Arabia AI Pharma Market Size, 2018-2029
        6.7.5 UAE AI Pharma Market Size, 2018-2029
7 AI Pharma Companies Profiles
    7.1 Recursion
        7.1.1 Recursion Company Summary
        7.1.2 Recursion Business Overview
        7.1.3 Recursion AI Pharma Major Product Offerings
        7.1.4 Recursion AI Pharma Revenue in Global Market (2018-2023)
        7.1.5 Recursion Key News & Latest Developments
    7.2 Insilico Medicine
        7.2.1 Insilico Medicine Company Summary
        7.2.2 Insilico Medicine Business Overview
        7.2.3 Insilico Medicine AI Pharma Major Product Offerings
        7.2.4 Insilico Medicine AI Pharma Revenue in Global Market (2018-2023)
        7.2.5 Insilico Medicine Key News & Latest Developments
    7.3 Exscientia
        7.3.1 Exscientia Company Summary
        7.3.2 Exscientia Business Overview
        7.3.3 Exscientia AI Pharma Major Product Offerings
        7.3.4 Exscientia AI Pharma Revenue in Global Market (2018-2023)
        7.3.5 Exscientia Key News & Latest Developments
    7.4 BenevolentAI
        7.4.1 BenevolentAI Company Summary
        7.4.2 BenevolentAI Business Overview
        7.4.3 BenevolentAI AI Pharma Major Product Offerings
        7.4.4 BenevolentAI AI Pharma Revenue in Global Market (2018-2023)
        7.4.5 BenevolentAI Key News & Latest Developments
    7.5 Atomwise
        7.5.1 Atomwise Company Summary
        7.5.2 Atomwise Business Overview
        7.5.3 Atomwise AI Pharma Major Product Offerings
        7.5.4 Atomwise AI Pharma Revenue in Global Market (2018-2023)
        7.5.5 Atomwise Key News & Latest Developments
    7.6 Roivant Sciences
        7.6.1 Roivant Sciences Company Summary
        7.6.2 Roivant Sciences Business Overview
        7.6.3 Roivant Sciences AI Pharma Major Product Offerings
        7.6.4 Roivant Sciences AI Pharma Revenue in Global Market (2018-2023)
        7.6.5 Roivant Sciences Key News & Latest Developments
    7.7 Schrödinger
        7.7.1 Schrödinger Company Summary
        7.7.2 Schrödinger Business Overview
        7.7.3 Schrödinger AI Pharma Major Product Offerings
        7.7.4 Schrödinger AI Pharma Revenue in Global Market (2018-2023)
        7.7.5 Schrödinger Key News & Latest Developments
    7.8 Lantern Pharma
        7.8.1 Lantern Pharma Company Summary
        7.8.2 Lantern Pharma Business Overview
        7.8.3 Lantern Pharma AI Pharma Major Product Offerings
        7.8.4 Lantern Pharma AI Pharma Revenue in Global Market (2018-2023)
        7.8.5 Lantern Pharma Key News & Latest Developments
    7.9 XtalPi
        7.9.1 XtalPi Company Summary
        7.9.2 XtalPi Business Overview
        7.9.3 XtalPi AI Pharma Major Product Offerings
        7.9.4 XtalPi AI Pharma Revenue in Global Market (2018-2023)
        7.9.5 XtalPi Key News & Latest Developments
    7.10 Landos Biopharma
        7.10.1 Landos Biopharma Company Summary
        7.10.2 Landos Biopharma Business Overview
        7.10.3 Landos Biopharma AI Pharma Major Product Offerings
        7.10.4 Landos Biopharma AI Pharma Revenue in Global Market (2018-2023)
        7.10.5 Landos Biopharma Key News & Latest Developments
    7.11 Relay Therapeutics
        7.11.1 Relay Therapeutics Company Summary
        7.11.2 Relay Therapeutics Business Overview
        7.11.3 Relay Therapeutics AI Pharma Major Product Offerings
        7.11.4 Relay Therapeutics AI Pharma Revenue in Global Market (2018-2023)
        7.11.5 Relay Therapeutics Key News & Latest Developments
    7.12 Accutar Biotech
        7.12.1 Accutar Biotech Company Summary
        7.12.2 Accutar Biotech Business Overview
        7.12.3 Accutar Biotech AI Pharma Major Product Offerings
        7.12.4 Accutar Biotech AI Pharma Revenue in Global Market (2018-2023)
        7.12.5 Accutar Biotech Key News & Latest Developments
    7.13 Deep Genomics
        7.13.1 Deep Genomics Company Summary
        7.13.2 Deep Genomics Business Overview
        7.13.3 Deep Genomics AI Pharma Major Product Offerings
        7.13.4 Deep Genomics AI Pharma Revenue in Global Market (2018-2023)
        7.13.5 Deep Genomics Key News & Latest Developments
    7.14 Oncocross
        7.14.1 Oncocross Company Summary
        7.14.2 Oncocross Business Overview
        7.14.3 Oncocross AI Pharma Major Product Offerings
        7.14.4 Oncocross AI Pharma Revenue in Global Market (2018-2023)
        7.14.5 Oncocross Key News & Latest Developments
    7.15 AI Therapeutics
        7.15.1 AI Therapeutics Company Summary
        7.15.2 AI Therapeutics Business Overview
        7.15.3 AI Therapeutics AI Pharma Major Product Offerings
        7.15.4 AI Therapeutics AI Pharma Revenue in Global Market (2018-2023)
        7.15.5 AI Therapeutics Key News & Latest Developments
    7.16 BioMap
        7.16.1 BioMap Company Summary
        7.16.2 BioMap Business Overview
        7.16.3 BioMap AI Pharma Major Product Offerings
        7.16.4 BioMap AI Pharma Revenue in Global Market (2018-2023)
        7.16.5 BioMap Key News & Latest Developments
    7.17 METiS Pharmaceuticals
        7.17.1 METiS Pharmaceuticals Company Summary
        7.17.2 METiS Pharmaceuticals Business Overview
        7.17.3 METiS Pharmaceuticals AI Pharma Major Product Offerings
        7.17.4 METiS Pharmaceuticals AI Pharma Revenue in Global Market (2018-2023)
        7.17.5 METiS Pharmaceuticals Key News & Latest Developments
    7.18 NeoX Biotech
        7.18.1 NeoX Biotech Company Summary
        7.18.2 NeoX Biotech Business Overview
        7.18.3 NeoX Biotech AI Pharma Major Product Offerings
        7.18.4 NeoX Biotech AI Pharma Revenue in Global Market (2018-2023)
        7.18.5 NeoX Biotech Key News & Latest Developments
    7.19 StoneWise
        7.19.1 StoneWise Company Summary
        7.19.2 StoneWise Business Overview
        7.19.3 StoneWise AI Pharma Major Product Offerings
        7.19.4 StoneWise AI Pharma Revenue in Global Market (2018-2023)
        7.19.5 StoneWise Key News & Latest Developments
    7.20 Deep Intelligent Pharma
        7.20.1 Deep Intelligent Pharma Company Summary
        7.20.2 Deep Intelligent Pharma Business Overview
        7.20.3 Deep Intelligent Pharma AI Pharma Major Product Offerings
        7.20.4 Deep Intelligent Pharma AI Pharma Revenue in Global Market (2018-2023)
        7.20.5 Deep Intelligent Pharma Key News & Latest Developments
    7.21 Gigaceuticals
        7.21.1 Gigaceuticals Company Summary
        7.21.2 Gigaceuticals Business Overview
        7.21.3 Gigaceuticals AI Pharma Major Product Offerings
        7.21.4 Gigaceuticals AI Pharma Revenue in Global Market (2018-2023)
        7.21.5 Gigaceuticals Key News & Latest Developments
    7.22 Chemical.AI
        7.22.1 Chemical.AI Company Summary
        7.22.2 Chemical.AI Business Overview
        7.22.3 Chemical.AI AI Pharma Major Product Offerings
        7.22.4 Chemical.AI AI Pharma Revenue in Global Market (2018-2023)
        7.22.5 Chemical.AI Key News & Latest Developments
    7.23 Artivila
        7.23.1 Artivila Company Summary
        7.23.2 Artivila Business Overview
        7.23.3 Artivila AI Pharma Major Product Offerings
        7.23.4 Artivila AI Pharma Revenue in Global Market (2018-2023)
        7.23.5 Artivila Key News & Latest Developments
    7.24 Galixir
        7.24.1 Galixir Company Summary
        7.24.2 Galixir Business Overview
        7.24.3 Galixir AI Pharma Major Product Offerings
        7.24.4 Galixir AI Pharma Revenue in Global Market (2018-2023)
        7.24.5 Galixir Key News & Latest Developments
    7.25 Xbiome
        7.25.1 Xbiome Company Summary
        7.25.2 Xbiome Business Overview
        7.25.3 Xbiome AI Pharma Major Product Offerings
        7.25.4 Xbiome AI Pharma Revenue in Global Market (2018-2023)
        7.25.5 Xbiome Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

AI Pharma Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?